Nektar Therapeutics Financial Flexibility Index
Nektar Therapeutics financial flexibility index. Nektar Therapeutics (NKTR) has a Financial Flexibility Index of -0.39x as of June 2026. Free cash flow of $-75.66 Million (operating CF $-75.77 Million minus capex $112.00K) represents 0% of total liabilities ($192.01 Million). See NKTR free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Nektar Therapeutics (1994–2025)
Financial flexibility index of Nektar Therapeutics from 1994 to 2025. Historical Financial Flexibility Index trend for Nektar Therapeutics across 32 annual periods. Check Nektar Therapeutics cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Nektar Therapeutics Financial Flexibility Index by Year (1994–2025)
Nektar Therapeutics financial flexibility index by year from 1994 to 2025. Year-by-year free cash flow to debt coverage for Nektar Therapeutics. For the full cash flow conversion analysis, see cash flow conversion of Nektar Therapeutics.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.09x | $-208.34 Million | $-208.51 Million | $190.57 Million | ▼ -52.5% |
| 2024 | -0.72x | $-174.24 Million | $-175.71 Million | $243.11 Million | ▲ +0.2% |
| 2023 | -0.72x | $-191.74 Million | $-192.61 Million | $267.05 Million | ▲ +17.2% |
| 2022 | -0.87x | $-298.33 Million | $-304.01 Million | $343.96 Million | ▲ +4.5% |
| 2021 | -0.91x | $-397.67 Million | $-412.66 Million | $437.68 Million | ▼ -37.0% |
| 2020 | -0.66x | $-306.03 Million | $-313.29 Million | $461.47 Million | ▼ -25.4% |
| 2019 | -0.53x | $-302.40 Million | $-328.68 Million | $571.97 Million | ▼ -131.2% |
| 2018 | 1.69x | $732.45 Million | $718.21 Million | $432.60 Million | ▲ +1107.8% |
| 2017 | -0.17x | $-70.74 Million | $-80.41 Million | $421.04 Million | ▲ +27.0% |
| 2016 | -0.23x | $-110.63 Million | $-117.02 Million | $480.75 Million | ▼ -84.3% |
| 2015 | -0.12x | $-61.89 Million | $-73.08 Million | $495.63 Million | ▲ +61.7% |
| 2014 | -0.33x | $-132.03 Million | $-142.01 Million | $405.29 Million | ▼ -396.1% |
| 2013 | -0.07x | $-34.44 Million | $-38.53 Million | $524.43 Million | ▲ +75.2% |
| 2012 | -0.26x | $-119.17 Million | $-129.76 Million | $450.77 Million | ▼ -3.9% |
| 2011 | -0.25x | $-104.02 Million | $-113.74 Million | $408.74 Million | ▼ -348.8% |
| 2010 | -0.06x | $-24.41 Million | $-55.87 Million | $430.56 Million | ▼ -144.4% |
| 2009 | 0.13x | $60.44 Million | $39.74 Million | $473.15 Million | ▲ +137.3% |
| 2008 | -0.34x | $-126.93 Million | $-145.78 Million | $370.38 Million | ▼ -197.7% |
| 2007 | 0.35x | $179.10 Million | $146.30 Million | $510.66 Million | ▲ +370.4% |
| 2006 | -0.13x | $-70.19 Million | $-92.72 Million | $541.12 Million | ▼ -14.9% |
| 2005 | -0.11x | $-60.04 Million | $-78.00 Million | $531.74 Million | ▲ +38.5% |
| 2004 | -0.18x | $-50.95 Million | $-78.14 Million | $277.58 Million | ▼ -44.6% |
| 2003 | -0.13x | $-57.45 Million | $-76.20 Million | $452.60 Million | ▲ +13.4% |
| 2002 | -0.15x | $-58.65 Million | $-74.97 Million | $399.87 Million | ▼ -253.8% |
| 2001 | -0.04x | $-16.45 Million | $-50.77 Million | $396.93 Million | ▼ -180.5% |
| 2000 | 0.05x | $18.11 Million | $-35.74 Million | $351.66 Million | ▲ +39.7% |
| 1999 | 0.04x | $5.17 Million | $-15.33 Million | $140.18 Million | ▼ -95.5% |
| 1998 | 0.83x | $15.36 Million | $-19.22 Million | $18.61 Million | ▼ -15.9% |
| 1997 | 0.98x | $22.24 Million | $4.98 Million | $22.67 Million | ▲ +274.4% |
| 1996 | -0.56x | $-3.60 Million | $-5.80 Million | $6.40 Million | ▲ +57.8% |
| 1995 | -1.33x | $-4.00 Million | $-5.30 Million | $3.00 Million | ▲ +7.7% |
| 1994 | -1.44x | $-2.60 Million | $-4.00 Million | $1.80 Million | — |